TRDA - Balance Sheet - Entrada Therapeutics, Inc.

Current Liabilities	39.5 M
Accounts Payable	4.26 M
Short-Term Debt	7.56 M
Other Current Liabilities	27.7 M
Non-Current Liabilities	58.2 M
Long-Term Debt	51.6 M
Other Non-Current Liabilities	6.51 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	101.2	67.6	45.2	291.1	39.0	16.8
Short Term Investments	318.8	284.4	143.6	0	0	0
Receivables	3.7	5.9	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	16.4	11.9	21.2	7.6	0.9	0.6
Total Current Assets	440.0	369.8	209.9	298.7	39.9	17.4
PP&E	82.0	92.7	33.0	6.3	3.0	0.8
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	4.0	0	0	0
Other Long Term Assets	4.2	6.7	5.2	0.9	0.5	(0.8)
Other Assets	0	0	0	0	0	0
Total Assets	526.3	469.2	252.1	305.8	43.5	18.2
LIABILITIES
Accounts Payable	4.3	3.3	6.0	0.7	1.6	0.7
Short Term Debt	7.6	14.9	16.8	0	0	0
Other Current Liabilities	13.3	11.3	(0.8)	6.0	1.8	1.2
Total Current Liabilities	39.5	158.8	22.0	6.7	3.4	1.9
Long Term Debt	51.6	60.3	17.5	0	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	6.5	0	0	0.4	0	31.8
Total Liabilities	97.6	226.8	39.5	7.1	85.0	33.8
EQUITY
Common Stock	4 K	3 K	3 K	3 K	1 K	1 K
Retained Earnings	(129.3)	(195.0)	(188.3)	(93.7)	(42.5)	(16.0)
Other Accumulative Comprehensive Income/Loss	43 K	0.2	(2.1)	(305.8)	(81.7)	(31.8)
Total Equity	428.7	242.4	212.6	298.7	(41.5)	(15.5)
Total Liabilities and Equity	526.3	469.2	252.1	305.8	43.5	18.2
SHARES OUTSTANDING
Common Shares Outstanding	37.3	33.1	31.3	31.2	31.2	31.2

Free